04-1263. Memorandum of Understanding Between the Food and Drug Administration and the Environmental Protection Agency, Office of Research and Development  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the U.S. Environmental Protection Agency (EPA), Office of Research and Development. The purpose of the MOU is to expedite research and development of new methods and technologies that can be implemented in support of Homeland Security efforts by Federal, State or local government entities as well as authorized private sector organizations to avert and/or mitigate the effects of terrorist activities in the United States.

    DATES:

    The agreement became effective February 19, 2003.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Frederick L. Fricke, Jr., Forensic Chemistry Center (HFR-CE500), Food and Drug Administration, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700, ext. 180.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: January 9, 2004.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature Start Printed Page 3149

    Start Printed Page 3150

    Start Printed Page 3151

    Start Printed Page 3152

    Start Printed Page 3153

    Start Printed Page 3154

    Start Printed Page 3155

    Start Printed Page 3156 End Supplemental Information

    BILLING CODE 4160-01-S

    [FR Doc. 04-1263 Filed 1-21-04; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Effective Date:
2/19/2003
Published:
01/22/2004
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
04-1263
Dates:
The agreement became effective February 19, 2003.
Pages:
3148-3156 (9 pages)
Docket Numbers:
FDA 225-04-4000
PDF File:
04-1263.pdf